ASCO Research

Check out these 7 abstracts powered by COTA’s RWD

Acute Myeloid Leukemia (AML)

Real-world (RW) use of venetoclax (VEN) in patients (pts) with acute myeloid leukemia (AML) in a US RWE database (COTA).

Breast Cancer

Outcomes among Hispanic metastatic breast cancer patients treated with alpelisib and fulvestrant: Single institution retrospective study.

Large B-cell Lymphoma (LBCL)

Racial and ethnic representation in large B-cell lymphoma trials and real-world databases.

Diffuse Large B-cell Lymphoma (DLBCL)

Real-world outcomes with novel therapies in R/R DLBCL.

Multiple Myeloma (MM)

An indirect comparison of elranatamab’s (ELRA) objective response rate (ORR) from MagnetisMM-3 (MM-3) vs real-world external control arms in triple-class refractory (TCR) multiple myeloma (MM).

Myelodysplastic Syndromes (MDS)

Real-world (RW) treatment (tx) patterns of patients (pts) with higher-risk myelodysplastic syndrome (MDS) in a US RWE database (COTA).

Non-small Cell Lung Cancer (NSCLC)

Real-world response endpoints in patients with mNSCLC treated with chemotherapy across real-world datasets.

Interested in learning more about how we can transform cancer care together?


Subscribe for Updates

Receive our latest news and research from thought leaders in the RWD industry
  • This field is for validation purposes and should be left unchanged.